Non-linear relationship of gamma-glutamyl transpeptidase to lymphocyte count ratio with the recurrence of hepatocellular carcinoma with staging I–II: a retrospective cohort study

[1] Bray FFJ(2018)Global Cancer Statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin 68 394-424

[2] Soerjomataram ISR(2019)Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics? Cancer Commun 39 22-608

[3] Torre LAJA(2016)Prognosis of hepatocellular carcinoma: assessment of eleven staging systems J Hepatol 64 601-4716

[4] Feng R(2018)Decreased levels of serum exosomal miR-638 predict poor prognosis in hepatocellular carcinoma J Cell Biochem 119 4711-371

[5] Zong Y(2018)Multidisciplinary management of recurrent and metastatic hepatocellular carcinoma after resection: an international expert consensus Hepatobiliary Surg Nutr 7 353-12

[6] Cao S(2019)Current perspectives on the immunosuppressive tumor microenvironment in hepatocellular carcinoma: challenges and opportunities Mol Cancer. 18 1-2023

[7] Xu R(2019)The systemic inflammatory response as a source of biomarkers and therapeutic targets in hepatocellular carcinoma Liver Int 39 2008-72289

[8] Liu P(2016)Prognostic significance of preoperative aspartate aminotransferase to neutrophil ratio index in patients with hepatocellular carcinoma after hepatic resection Oncotarget 7 72276-297

[9] Hsu C(2020)Estimation of hepatocellular carcinoma mortality using aspartate aminotransferase to platelet ratio index J Gastrointest Oncol 11 291-11

[10] Hsia C(2019)The preoperative platelet to albumin ratio predicts the prognosis of hepatocellular carcinoma patients without portal hypertension after liver resection Medicine. 98 e17920-33

[1] Bray FFJ(2018)Global Cancer Statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin 68 394-424

[2] Soerjomataram ISR(2019)Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics? Cancer Commun 39 22-608

[3] Torre LAJA(2016)Prognosis of hepatocellular carcinoma: assessment of eleven staging systems J Hepatol 64 601-4716

[4] Feng R(2018)Decreased levels of serum exosomal miR-638 predict poor prognosis in hepatocellular carcinoma J Cell Biochem 119 4711-371

[5] Zong Y(2018)Multidisciplinary management of recurrent and metastatic hepatocellular carcinoma after resection: an international expert consensus Hepatobiliary Surg Nutr 7 353-12

[6] Cao S(2019)Current perspectives on the immunosuppressive tumor microenvironment in hepatocellular carcinoma: challenges and opportunities Mol Cancer. 18 1-2023

[7] Xu R(2019)The systemic inflammatory response as a source of biomarkers and therapeutic targets in hepatocellular carcinoma Liver Int 39 2008-72289

[8] Liu P(2016)Prognostic significance of preoperative aspartate aminotransferase to neutrophil ratio index in patients with hepatocellular carcinoma after hepatic resection Oncotarget 7 72276-297

[9] Hsu C(2020)Estimation of hepatocellular carcinoma mortality using aspartate aminotransferase to platelet ratio index J Gastrointest Oncol 11 291-11

[10] Hsia C(2019)The preoperative platelet to albumin ratio predicts the prognosis of hepatocellular carcinoma patients without portal hypertension after liver resection Medicine. 98 e17920-33